4169 — Tcm Biotech International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Tcm Biotech International, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	58.3	89.9	504	533	545
Net Total Accounts Receivable
Net Total Receivables	191	230	263	142	151
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	470	514	981	812	858
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	285	302	294	292	281
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	820	863	1,323	1,182	1,204
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	176	225	198	81.9	115
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	302	326	268	123	149
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	518	537	1,055	1,059	1,055
Total Liabilities & Shareholders' Equity	820	863	1,323	1,182	1,204
Total Common Shares Outstanding